M46.58
Other infective spondylopathies, sacral and sacrococcygeal region
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code M46.58 refers to a group of medical conditions known as other infective spondylopathies occurring specifically in the sacral and sacrococcygeal regions of the spine. These are infections that affect the vertebrae in the lower back involved with the sacrum and coccyx, which are critical components of the pelvis. While these conditions are less common than infections in other parts of the spine, they can lead to significant health problems if left untreated. Recognizing these conditions involves understanding their causes, symptoms, methods of diagnosis, and potential treatments.
Causes & Symptoms
Clinical Causes: Bacterial infections such as Staphylococcus aureus or Mycobacterium tuberculosis that reach the vertebrae through the bloodstream or direct invasion. Spread of infections from nearby tissues or organs, such as the intestines or urinary tract. Open wounds or procedures involving the spine or pelvis that introduce infectious agents. Weakened immune system, which increases the susceptibility to infections. Pre-existing chronic infections that can localize to the spine bones.
Key Symptoms: Persistent back pain localized to the lower back and sacrococcygeal region. Swelling or tenderness over the affected area. Fever and chills, often indicating an active infection. General malaise or fatigue. Difficulty sitting or painful movement in the lower back. Potential neurological symptoms if the infection compresses spinal nerves, such as numbness or weakness. In some cases, drainage from the affected area.
Diagnostic & Treatment
Diagnosis Path: Diagnosing infective spondylopathies in the sacral and sacrococcygeal regions involves a combination of medical assessments and diagnostic tests. Healthcare providers typically perform a detailed physical examination, noting tenderness, swelling, and neurological deficits. Imaging techniques such as MRI are crucial for visualizing inflammation, abscess formation, or destruction of the vertebrae. Blood tests can detect signs of infection, including elevated inflammatory markers like ESR and CRP. In certain cases, a biopsy or microbiological culture of tissue or fluid samples from the affected area is necessary to identify the causative organism, guiding targeted therapy.
Treatment Protocols: Management of these infective conditions usually involves a combination of therapies aimed at eradicating the infection and preserving spinal integrity. Antibiotic therapy tailored to the specific pathogen is the mainstay of treatment and may be administered intravenously initially, followed by oral medications. In more severe cases, surgical intervention may be required to drain abscesses, debride infected tissue, or stabilize the spine if structural damage is present. Pain management, physical therapy, and infection control measures form essential components of comprehensive care. Early diagnosis and effective treatment are vital to prevent complications like spinal instability or nerve damage.
Clinical Advice & FAQs
Billing Guidance
Is M46.58 a billable ICD-10 code?
Yes, M46.58 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M46.58?
Clinical documentation must specify the nature of Other infective spondylopathies, sacral and sacrococcygeal region and any associated comorbidities for accurate reporting.
Cite this Clinical Reference